|
3021
|
DL5050
|
Potent and highly selective hCAR agonist |
€140.00
|
|
2561
|
DY 268
|
Highly potent FXR antagonist with a promising in vitro profile |
€120.00
|
|
2363
|
GSK 2033
|
The first potent cell-active LXR antagonist |
€105.00
|
|
1266
|
GW 3965 hydrochloride
|
Liver X receptor agonist |
€95.00
|
|
2357
|
LXR 623
|
Partial agonist of Liver X Receptor |
€95.00
|
|
3174
|
Obeticholic acid
|
Potent and selective FXR agonist |
€60.00
|
|
2152
|
PX 20350
|
Potent farnesoid X receptor (FXR) agonist |
€105.00
|
|
3739
|
RGX-104
|
Liver X receptor (LXR) agonist |
Inquire
|
|
2598
|
SR 9243
|
LXR inverse agonist inhibiting the Warburg effect and lipogenesis in cancer cells |
€85.00
|
|
2754
|
T0901317
|
Liver X receptor (LXR) agonist |
€75.00
|
|
3411
|
TCPOBOP
|
CAR agonist |
€70.00
|
|
1749
|
WAY 362450
|
Farnesoid X receptor (FXR) agonist |
€125.00
|
|
1991
|
WYE 672
|
Liver X receptor (LXR) agonist |
€120.00
|